University · founded 1911
Anderson University - South Carolina
Anderson, United States · andersonuniversity.edu
- Citations, last 5 years
- 1 240
- Works, last 5 years
- 169
- h-index
- 34
- Scientists listed
- 11
- Grants since 2016
- 1 743
Grants received
2019–2021 · fellowship · F31
The signaling role of alveolar type 1 cell-derived Wnt ligands during alveologenesis
Odemaris Narvaez Del Pilar · Anderson University - South Carolina · funded by National Institutes of Health
2019 · research · R01
Enhancing immune mediated head and neck cancer anti-tumor activity using nanoparticles
Sunil Krishnan · Anderson University - South Carolina · funded by National Institutes of Health
2019–2025 · research · R01
A Novel Hsp90 Inhibitor as a Chemo and Radiosensitizer in Adults with Glioblastoma
Vinay K Puduvalli · Anderson University - South Carolina · funded by National Institutes of Health
2019–2025 · cooperative agreement · UG1
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP) UG1
Kelly K Hunt · Anderson University - South Carolina · funded by National Institutes of Health
2019–2026 · research · R01
Synthetic lethality based combination approaches to ARID1A mutation in ovarian cancer
Rugang Zhang · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Developing Novel Therapeutic Approaches Targeting Macrophages in GBM
Y. Alan Wang · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Therapeutic strategies against EGFR exon 20 mutant lung cancer
John V. Heymach · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · cooperative agreement · U01
Patient-Derived Models of Prostate Cancer for Personalized Medicine
Yu Chen · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Development of Long non-coding RNA-directed Target Therapy for Triple-Negative Breast Cancer
Chunru Lin · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Adoptive T Cell Therapy for Pancreatic Cancer
Cassian Yee · Anderson University - South Carolina · funded by National Institutes of Health
2019–2022 · research · R21
3D Imaging of Tumor Mechanobiology Using Nanobomb Optical Coherence Elastography
Konstantin V Sokolov · Anderson University - South Carolina · funded by National Institutes of Health
2019–2025 · research · R01
Ph1/2 Study of the Imipridone ONC201 for Treatment of AML IND125,203 (12/23/2014)
Michael Andreeff · Anderson University - South Carolina · funded by U.S. Food and Drug Administration
2019–2024 · research · R01
The molecular and immune evolution in the progression of lung neoplasia to invasive adenocarcinoma
Jianjun Zhang · Anderson University - South Carolina · funded by National Institutes of Health
2019–2023 · research · R01
Dynamic Prediction of Renal Failure Using Longitudinal Prognostic Information among Patients with Chronic Kidney Disease and Kidney Transplant
Brad C Astor · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
INVESTIGATING TUMOR INITIATION AND INVASION IN PREMALIGNANT BREAST CANCER WITH SPATIAL SINGLE CELL GENOMICS
Nicholas Navin · Anderson University - South Carolina · funded by National Institutes of Health
2019–2022 · fellowship · F32
Mechanisms by which mutant p53 drives metastatic Triple Negative Breast Cancer
Joy Marie Mcdaniel · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R35
Genetic and Molecular Definition of Histone Modifying Enzyme Functions
Sharon Y. R. Dent · Anderson University - South Carolina · funded by National Institutes of Health
2019–2021 · research · R21
Targeting the Unique Paracaspase MALT1 to Overcome Ibrutinib Resistance in Relapsed/Refractory MCL Patients
Changying Jiang · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · career development · K08
The role of ARF6 in the progression of diabetic kidney disease
Jamie Lin · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Characterizing heterochromatin dysfunction as a driving alteration in cancer
Jason Huse · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · program · P50
The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma
Laura Beretta · Anderson University - South Carolina · funded by National Institutes of Health
2019–2022 · research · R21
Developing a NF-κB/GADD45b targeting strategy for glioblastoma
Krishna Pl Bhat · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer
Cullen Mitsuo Taniguchi · Anderson University - South Carolina · funded by National Institutes of Health
2019 · research · R01
Biomarker screening algorithms for the improved early detection of hepatocellular carcinoma
Nabihah Tayob · Anderson University - South Carolina · funded by National Institutes of Health
2019–2023 · research · R01
A novel natural history study of medullary thyroid carcinoma: Incorporating the patient perspective to inform advanced disease management
Elizabeth Gardner Grubbs · Anderson University - South Carolina · funded by U.S. Food and Drug Administration
2019–2020 · research · R21
Measuring Tumor Acidosis with PET/MRI Contrast Agents
Mark David Pagel · Anderson University - South Carolina · funded by National Institutes of Health
2019–2020 · research · R13
International Conference on Novel Strategies to Prevent Cancer by Targeting Infection, Inflammation, and the Immune System
Powel H Brown · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Development and Dissemination of Clinical CEST MRI Acquisition and Analysis Methods for Cancer Imaging Applications
Jingfei Ma · Anderson University - South Carolina · funded by National Institutes of Health
2019–2023 · research · R01
REST-mediated epigenomic and transcriptomic signatures in neuropathic pain
Sadhan Majumder · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · RF1
Dnmt3a as an epigenetic target for chronic pain treatment
Zhizhong Z. Pan · Anderson University - South Carolina · funded by National Institutes of Health
2019–2026 · research · R35
Inducible epithelial resistance: a program investigating mechanisms to protect against acute and chronic complications of pneumonia
Scott E. Evans · Anderson University - South Carolina · funded by National Institutes of Health
2019–2025 · career development · K08
Chromatin Modifier Gene Mutation and Enhancer Dysfunction in Bladder Cancer
Byron H Lee · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
INVESTIGATING TUMOR INITIATION AND INVASION IN PREMALIGNANT BREAST CANCER WITH SPATIAL SINGLE CELL GENOMICS
Nicholas Navin · Anderson University - South Carolina · funded by National Institutes of Health
2019–2023 · research · R01
Pathological flow-induced endothelial damage and plaque erosion
Jun-Ichi Abe · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Development of Long non-coding RNA-directed Target Therapy for Triple-Negative Breast Cancer
Chunru Lin · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · cooperative agreement · U01
Patient-Derived Models of Prostate Cancer for Personalized Medicine
Yu Chen · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · research · R01
Therapeutic strategies against EGFR exon 20 mutant lung cancer
John V. Heymach · Anderson University - South Carolina · funded by National Institutes of Health
2019–2021 · research · R21
Molecularly targeted photothermal ablation to enhance the therapeutic efficacy of immunomodulatory therapies in hepatocellular carcinoma
Rahul Anil Sheth · Anderson University - South Carolina · funded by National Institutes of Health
2019–2023 · research · R01
Pathological flow-induced endothelial damage and plaque erosion
Jun-Ichi Abe · Anderson University - South Carolina · funded by National Institutes of Health
2019–2024 · career development · K08
The role of ARF6 in the progression of diabetic kidney disease
Jamie Lin · Anderson University - South Carolina · funded by National Institutes of Health
